With respect to GK, cancer tissue expression of GK-5 (both mRNA and protein), as well as elevated exosomal GK-5 mRNA levels in plasma, were reported in patients with gefitinib-resistant compared to gefitinib-sensitive lung adenocarcinoma (256). This evidence concerns the gene GK5 and lung adenocarcinoma.